Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

XenoPort, Inc. announced the appointment of Dennis M. Fenton, Ph.D., to its board of directors. Dr. Fenton has over 30 years of pharmaceutical and biotechnology experience, including over 25 years at Amgen Inc., a biotechnology company.

 

Today in Execs on the Move...keeping you current

The Joint Commission Names Charles R. Buck to Board of Commissioners, Connie S. March to Represent Long Term Care Field
Joint Commission news, 12/07/09

Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
American Pharmaceutical Partners, 12/03/09

Cardinal Health names Carrie Cox to board of directors
Cardinal Health, 12/03/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address